N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide

We are N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide CAS:262368-30-9 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide
CAS.NO:262368-30-9
Synonyms:N-[(4-methyl-piperazin-1-yl)-methylcarbonyl]-N-methyl-p-phenyldiamine
Molecular Formula:C14H22N4O
Molecular Weight:262.35100
 
Physical and Chemical Properties:
Melting point:152-154ºC
 
Specification:
Appearance:Off-White to pale beige solid
Purity:≥99.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Nintedanib
 
Note:The product under valid patents will not be offered to the countries covered by patents.

N-(4-aminophenyl)-N-methyl-2-(4-methylpiperazin-1-yl)acetamide


Related News: The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.Poly(methylhydrosiloxane) CAS:63148-57-2;9004-73-3 The use of contrast agents is different from other drugs, and it needs to be used with corresponding equipment. In recent years, China is in the growth period of imaging equipment.693-58-3 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.Ácido 4-etilfenilborónico CAS:63139-21-9 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.

Related Products
Product Name
5-Bromo-2,4-difluoroaniline View Details
2-Amino-5-nitrophenol View Details
3-Ethoxyacryloyl chloride View Details
2-BROMO-6-FLUOROANILINE manufacturer 4-methyl-4-methylsulfanylpentan-2-one manufacturer 2′-bromo-biphenyl-4-carbonitrile manufacturer Acetyl Tetrapeptide-22 manufacturer N-[4-[4-[[4-(diphenylamino)phenyl]-(1-naphthyl)amino]phenyl]pheny l]-N-(1-naphthyl)-N’,N’-diphenyl-benzene-1,4-diamine manufacturer